Citigroup Inc Palatin Technologies Inc Transaction History

Citigroup Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$0.27 - $0.5 $2,565 - $4,750	9,500 Added 395.83%	11,900 $3,000
Q1 2022 May 12, 2022	SELL	$0.37 - $0.54 $1,480 - $2,160	-4,000 Reduced 62.5%	2,400 $1,000
Q3 2021 Nov 10, 2021	BUY	$0.44 - $0.63 $2,816 - $4,032	6,400 New	6,400 $3,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $10.4M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.